Stocks
Ultragenyx Pharmaceutical Inc.RARE
NASDAQHealthcareBiotechnology$21.34-1.70%
Focused on therapies for rare and ultra-rare genetic diseases, this biotechnology company develops and commercializes treatments targeting conditions with limited existing options. Its portfolio includes approved drugs for metabolic and skeletal disorders alongside a pipeline of gene therapy and bio...
Market Cap: $2.1B52W Range: $18.41 – $42.37
Congressional Interest in Ultragenyx Pharmaceutical Inc. (RARE)
2 members of Congress have disclosed 3 trades in Ultragenyx Pharmaceutical Inc. (RARE), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
2
Sells
1
Who in Congress Is Trading RARE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-08-08 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-07-15 | Gilbert Cisneros | buy | $1K – $15K |